The global sterile dosage form market, valued at USD 582.9 million in 2023, is projected to expand at a CAGR of 6.7%, surpassing USD 1.1 billion by 2033. This growth reflects the increasing demand for safe and sterile pharmaceutical products, driven by advancements in drug delivery systems and the need for high-quality formulations in healthcare. …